Zogenix Competitors and Similar CompaniesClear all
Zogenix's competitors and similar companies include Societal CDMO, Avid Bioservices, Amicus Therapeutics and Tricida.
 Zogenix Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology. |  Societal CDMO Recro Gainesville (also known as Recro Pharma) is a clinical-stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of acute post-operative pain. |  Avid Bioservices Avid Bioservices, formerly Peregrine Pharmaceuticals, is a biopharmaceutical company. |  Amicus Therapeutics Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases. | ||
Founding Date | Founding Date 2006 | Founding Date 2006 | Founding Date 1981 | Founding Date 2002 | Founding Date 2013 |
Type | Type Subsidiary | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Emeryville, US HQ Maidenhead, GB | Locations Gainesville, US HQ Gainesville, US San Diego, US | Locations Tustin, US HQ | Locations Philadelphia, US HQ Northbridge, AU Pointe Claire, CA Paris, FR München, DE Dublin, IE Milano, IT see more | Locations South San Francisco, US HQ |
Employees | Employees 743% increase | Employees 21316% decrease | Employees 21114% increase | Employees 58415% increase | Employees 11914% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 116.1 m | Valuation ($) 649.4 m | Valuation ($) 3.4 b | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $81.7m (FY, 2021) | Revenue (est.) $94.6m (FY, 2023) | Revenue (est.) $139.9m (FY, 2024) | Revenue (est.) $634.2m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods $4.8m (FY, 2021) | Cost of goods $76.5m (FY, 2023) | Cost of goods $132.6m (FY, 2024) | Cost of goods $72.9m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit $7.3m (FY, 2024) | Gross profit $561.3m (FY, 2025) | Gross profit N/A |
Net income | Net income ($227.4m) (FY, 2021) | Net income ($13.3m) (FY, 2023) | Net income ($140.8m) (FY, 2024) | Net income ($27.1m) (FY, 2025) | Net income ($176.6m) (FY, 2021) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 88m | Total funding raised $ 157m |
For sources of this data, please see the company profile
View Company Profiles
Societal CDMO
HQ
Gainesville, US
Employees
213↓ 16% decrease
Recro Gainesville (also known as Recro Pharma) is a clinical-stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of acute post-operative pain.
View companyAvid Bioservices
HQ
Tustin, US
Employees
211↑ 14% increase
Avid Bioservices, formerly Peregrine Pharmaceuticals, is a biopharmaceutical company.
View companyAmicus Therapeutics
HQ
Philadelphia, US
Employees
584↑ 15% increase
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
View company
Tricida
HQ
South San Francisco, US
Employees
119↑ 14% increase
Tricida operates in the healthcare industry focusing on pharmaceutical business.
View company